Literature DB >> 2532074

Circadian variation of plasma fibrinopeptide A level in patients with variant angina.

H Ogawa1, H Yasue, S Oshima, K Okumura, K Matsuyama, K Obata.   

Abstract

Plasma levels of fibrinopeptide A (FPA), beta-thromboglobulin (BTG), and platelet factor 4 (PF4) were examined on venous plasma samples taken every 4 hours for 24 hours in 20 patients with variant angina and 20 patients with stable exertional angina together with 24-hour Holter recordings. The mean plasma FPA levels (ng/ml) at 2:00 PM, 6:00 PM, 10:00 PM, 2:00 AM, 6:00 AM, and 10:00 AM were 4.6 +/- 1.0, 3.1 +/- 0.5, 6.1 +/- 1.6, 9.9 +/- 2.4, 8.7 +/- 1.4, and 4.2 +/- 0.8 in patients with variant angina (p less than 0.01) and 1.8 +/- 0.2, 2.3 +/- 0.3, 1.9 +/- 0.3, and 2.3 +/- 0.2 in those with stable exertional angina. In seven patients with variant angina, we also examined the effects of heparin (3,000 units), given subcutaneously at 6:00 PM, 10:00 PM, and 2:00 AM, on the plasma FPA levels and the anginal attacks. Although heparin suppressed the elevation and circadian variation of plasma FPA levels, it did not suppress the attacks and their circadian variation in these patients. Plasma FPA levels increased significantly from 3.7 +/- 0.5 to 12.5 +/- 2.7 ng/ml during or immediately after an attack in the seven patients with no heparin. On the other hand, the plasma levels of BTG and PF4 were increased in patients with variant angina as compared with those with stable exertional angina but did not show a significant circadian variation in both groups. We conclude that 1) plasma levels of FPA, BTG, and PF4 were increased in patients with variant angina as compared with those with stable exertional angina; 2) there was a significant circadian variation in the plasma levels of FPA in parallel with that of the frequency of the attacks with the peak level occurring from midnight to early morning in patients with variant angina; and 3) elevated levels of plasma FPA are the result and not the cause of coronary spasm.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532074     DOI: 10.1161/01.cir.80.6.1617

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Multifocal spasm with acetylcholine in Prinzmetal angina.

Authors:  H R Michels; H F Baars
Journal:  Neth Heart J       Date:  2008-04       Impact factor: 2.380

Review 2.  Pathobiology and evolving therapies of coronary artery vasospasm.

Authors:  Monish A Sheth; Robert J Widmer; Hari K Dandapantula
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-04-21

3.  Influence of the Circadian System on Disease Severity.

Authors:  Mikhail Litinski; Frank Ajl Scheer; Steven A Shea
Journal:  Sleep Med Clin       Date:  2009-06-01

4.  Effects of beraprost sodium, a new prostaglandin I2 analog, on parameters of hemostasis, fibrinolysis, and myocardial ischemia in patients with exertional angina.

Authors:  K Sakata; T Hoshino; H Yoshida; T Kaburagi; A Takada
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

5.  An atypical case of vasospastic angina: demonstrating the usefulness of Holter monitoring.

Authors:  Naveen Chandra Ganiga Sanjeeva; Ranjan K Shetty; Sumit Agarwal
Journal:  BMJ Case Rep       Date:  2015-08-25

6.  Circadian variation in fibrinolytic activity in patients with variant angina.

Authors:  T Masuda; H Ogawa; Y Miyao; Q Yu; I Misumi; T Sakamoto; H Okubo; K Okumura; H Yasue
Journal:  Br Heart J       Date:  1994-02

7.  Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years.

Authors:  Koji Sato; Koichi Kaikita; Naoki Nakayama; Eiji Horio; Hiromi Yoshimura; Takamichi Ono; Keisuke Ohba; Kenichi Tsujita; Sunao Kojima; Shinji Tayama; Seiji Hokimoto; Kunihiko Matsui; Seigo Sugiyama; Hiroshige Yamabe; Hisao Ogawa
Journal:  J Am Heart Assoc       Date:  2013-07-15       Impact factor: 5.501

8.  Intermittent left bundle branch block caused by coronary vasospasm.

Authors:  Mohammad Alhaji
Journal:  Avicenna J Med       Date:  2013-04

9.  Determinants of Myocardial Lactate Production During Acetylcholine Provocation Test in Patients With Coronary Spasm.

Authors:  Koichi Kaikita; Masanobu Ishii; Koji Sato; Masafumi Nakayama; Yuichiro Arima; Tomoko Tanaka; Koichi Sugamura; Kenji Sakamoto; Yasuhiro Izumiya; Eiichiro Yamamoto; Kenichi Tsujita; Megumi Yamamuro; Sunao Kojima; Hirofumi Soejima; Seiji Hokimoto; Kunihiko Matsui; Hisao Ogawa
Journal:  J Am Heart Assoc       Date:  2015-12-11       Impact factor: 5.501

Review 10.  Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery disease.

Authors:  Satoru Suzuki; Koichi Kaikita; Eiichiro Yamamoto; Hideaki Jinnouchi; Kenichi Tsujita
Journal:  Cardiovasc Interv Ther       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.